The Search for an Optimal DNA, RNA, and Protein Detection by in Situ Hybridization, Immunohistochemistry, and Solution-based Methods
Overview
Authors
Affiliations
Clinical trials and correlative laboratory research are increasingly reliant upon archived paraffin-embedded samples. Therefore, the proper processing of biological samples is an important step to sample preservation and for downstream analyses like the detection of a wide variety of targets including micro RNA, DNA and proteins. This paper analyzed the question whether routine fixation of cells and tissues in 10% buffered formalin is optimal for in situ and solution phase analyses by comparing this fixative to a variety of cross linking and alcohol (denaturing) fixatives. We examined the ability of nine commonly used fixative regimens to preserve cell morphology and DNA/RNA/protein quality for these applications. Epstein-Barr virus (EBV) and bovine papillomavirus (BPV)-infected tissues and cells were used as our model systems. Our evaluation showed that the optimal fixative in cell preparations for molecular hybridization techniques was "gentle" fixative with a cross-linker such as paraformaldehyde or a short incubation in 10% buffered formalin. The optimal fixatives for tissue were either paraformaldehyde or low concentration of formalin (5% of formalin). Methanol was the best of the non cross-linking fixatives for in situ hybridization and immunohistochemistry. For PCR-based detection of DNA or RNA, some denaturing fixatives like acetone and methanol as well as "gentle" cross-linking fixatives like paraformaldehyde out-performed other fixatives. Long term fixation was not proposed for DNA/RNA-based assays. The typical long-term fixation of cells and tissues in 10% buffered formalin is not optimal for combined analyses by in situ hybridization, immunohistochemistry, or--if one does not have unfixed tissues--solution phase PCR. Rather, we recommend short term less intense cross linking fixation if one wishes to use the same cells/tissue for in situ hybridization, immunohistochemistry, and solution phase PCR.
Colburn M, Delaney M, Anchor G, Terio K J Vet Diagn Invest. 2024; 36(4):498-505.
PMID: 38650110 PMC: 11185121. DOI: 10.1177/10406387241245777.
Using In Situ Padlock Probe Technology to Detect mRNA Splice Variants in Tumor Cells.
Hofmann L, Kroneis T, El-Heliebi A Methods Mol Biol. 2020; 2148:361-378.
PMID: 32394394 DOI: 10.1007/978-1-0716-0623-0_23.
Zhu Y, Meszaros J, Walle R, Fan R, Sun Z, Dwork A Biotechniques. 2019; 68(3):122-129.
PMID: 31859535 PMC: 7092707. DOI: 10.2144/btn-2019-0083.
Resende T, Marshall Lund L, Rossow S, Vannucci F Front Vet Sci. 2019; 6:403.
PMID: 31803766 PMC: 6873589. DOI: 10.3389/fvets.2019.00403.
Vasquez J, Hussien R, Aguilar-Rodriguez B, Junger H, Dobi D, Henrich T J Histochem Cytochem. 2018; 66(6):427-446.
PMID: 29462571 PMC: 5977441. DOI: 10.1369/0022155418756848.